Health.Global

Market Cap: Small Cap
Industry: Hospital
ISIN: INE075I01017
NSEID: HCG
BSEID: 539787

INR

720.65

4.4 (0.61%)

BSENSE

Dec 05

BSE+NSE Vol: 2.26 lacs

{
  "main_header": {
    "sid": 1002586,
    "name": "Health.Global",
    "stock_name": "Health.Global",
    "full_name": "Healthcare Global Enterprises Ltd",
    "name_url": "stocks-analysis/healthglobal",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "720.65",
    "chg": 4.4,
    "chgp": "0.61%",
    "dir": 1,
    "prev_price": "716.25",
    "mcapval": "10,153.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 539787,
    "symbol": "HCG",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE075I01017",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "2.26 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/healthglobal-1002586-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Health.Global technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-healthglobal-technically-bullish-or-bearish-3745631",
        "imagepath": "",
        "date": "2025-12-04 08:43:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Current Technical Trend</strong></p>\n<p>As of 3 December 2025, Health.Global's technical trend has shifted from a clear bullish stance to a mildly bullish one. This subtle change indicates that while the stock retains some upward momentum, the strength of the trend has softened. Investors should note that a mildly bullish trend often signals a period of consolidation or a potential pause before the next significant move.</p>\n<p><strong>Key Technical Indicators: Mixed Signals</strong></p>\n<p>Examining the Moving Average Convergence Divergence (MACD), a widely used momentum indicator, reveals a split between weekly and monthly perspectives. The weekly MACD is mildly bearish, suggesting short-term momentum is weakening. Conversely, the monthly MACD remains bullish, indicating that t..."
      },
      {
        "title": "Healthcare Global Enterprises Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/healthcare-global-enterprises-technical-momentum-shifts-amid-mixed-indicator-signals-3745507",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/HealthcareGloba_technicaldot_3745507.png",
        "date": "2025-12-04 08:11:33",
        "description": "Healthcare Global Enterprises, a key player in the hospital sector, has experienced a nuanced shift in its technical parameters, reflecting a complex interplay of price momentum and indicator signals. Recent market data reveals a transition from a bullish to a mildly bullish trend, with mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting a cautious outlook for investors."
      },
      {
        "title": "Healthcare Global Enterprises Shows Mixed Technical Signals Amid Strong Long-Term Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/healthcare-global-enterprises-shows-bullish-technical-momentum-amid-mixed-indicators-3742980",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/HealthcareGloba_technicaldot_3742980.png",
        "date": "2025-12-03 08:07:51",
        "description": "Healthcare Global Enterprises, a key player in the hospital sector, is exhibiting a nuanced shift in its technical momentum as recent evaluation adjustments reflect a transition from mildly bullish to bullish trends. While short-term indicators present a mixed picture, the company’s long-term returns continue to outpace broader market benchmarks, underscoring its resilience in a competitive industry."
      },
      {
        "title": "Healthcare Global Enterprises Shows Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/healthcare-global-enterprises-shows-mixed-technical-signals-amid-price-momentum-shift-3740294",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/HealthcareGloba_technicaldot_3740294.png",
        "date": "2025-12-02 08:10:37",
        "description": "Healthcare Global Enterprises has experienced a nuanced shift in its technical landscape, reflecting a complex interplay of momentum indicators and moving averages. Recent price action and technical parameters suggest a transition from a bullish to a mildly bullish trend, with key indicators offering a mixed outlook for investors analysing the hospital sector stock."
      },
      {
        "title": "Healthcare Global Enterprises Sees Shift in Market Assessment Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/healthcare-global-enterprises-upgraded-to-hold-on-improved-quality-and-valuation-metrics-3727897",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/HealthcareGloba_mojoScore_3727897.png",
        "date": "2025-11-25 08:51:33",
        "description": "Healthcare Global Enterprises has experienced a notable revision in its market evaluation, reflecting changes across quality, valuation, financial trends, and technical indicators. This shift comes amid a backdrop of strong long-term returns contrasted by recent flat financial performance and elevated debt levels, prompting a nuanced reassessment of the hospital sector stock."
      },
      {
        "title": "Is Health.Global overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-healthglobal-overvalued-or-undervalued-3727372",
        "imagepath": "",
        "date": "2025-11-25 08:19:35",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Understanding Health.Global’s Valuation Metrics</strong></p>\n<p>At first glance, Health.Global’s price-to-earnings (PE) ratio stands at an exceptionally elevated level, exceeding 280. This figure is significantly higher than typical industry standards and peer averages, which might initially suggest overvaluation. However, the company’s price-to-book value of around 11 and an enterprise value to EBITDA multiple near 27.5 indicate that investors are pricing in substantial growth potential and operational efficiency.</p>\n<p>Moreover, the enterprise value to capital employed ratio of approximately 4.7 and EV to sales near 4.9 further illustrate that the market is valuing the company’s capital base and revenue generation at a premium. These multiples, while high, are not unprecedented in the hos..."
      },
      {
        "title": "Healthcare Global Enterprises: Valuation Shifts Highlight Price Attractiveness in Hospital Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/healthcare-global-enterprises-valuation-shifts-signal-renewed-price-attractiveness-3727295",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/HealthcareGloba_valuationdot_3727295.png",
        "date": "2025-11-25 08:00:46",
        "description": "Healthcare Global Enterprises has experienced a notable revision in its valuation parameters, reflecting a shift in market assessment that positions the stock as more price attractive relative to its historical and peer benchmarks. This development invites a closer examination of key financial metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios within the context of the hospital sector."
      },
      {
        "title": "Healthcare Global Enterprises: An In-Depth Analysis of Business Fundamentals and Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/healthcare-global-enterprises-quality-metrics-improve-amid-mixed-financial-fundamentals-3727247",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/HealthcareGloba_qualitydot_3727247.png",
        "date": "2025-11-25 08:00:06",
        "description": "Healthcare Global Enterprises has recently undergone a revision in its evaluation metrics, reflecting changes in its business fundamentals and market standing. This article analyses key financial parameters such as return on equity, return on capital employed, debt levels, and growth trends to provide a comprehensive view of the company's current position within the hospital sector."
      },
      {
        "title": "How has been the historical performance of Health.Global?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-healthglobal-3726396",
        "imagepath": "",
        "date": "2025-11-24 23:20:59",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Operating Performance</strong></p>\n<p>Health.Global’s net sales have shown consistent growth, rising from ₹978.67 crores in March 2019 to ₹2,222.85 crores in March 2025. This represents a compound annual growth rate (CAGR) of approximately 15.5%, reflecting the company’s expanding market presence and operational scale. Total operating income mirrors this trend, as other operating income remained nil throughout the period.</p>\n<p>The company’s operating profit before depreciation and interest (PBDIT) excluding other income increased from ₹125.19 crores in 2019 to ₹387.28 crores in 2025, with operating profit margins stabilising around 17.4% in recent years. This improvement underscores enhanced operational efficiency and cost management, despite rising expenditure on purchases of ..."
      }
    ],
    "total": 212,
    "sid": "1002586",
    "stock_news_url": "https://www.marketsmojo.com/news/healthcare-global-enterprises-1002586"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "01-Dec-2025",
      "details": "Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that based on the recommendation of the Audit Committee and the Nomination and Remuneration Committee the Board of Directors of the Company at its meeting held on December 01 2025 has approved the appointment of Dr. Manish Mattoo Executive Director and Chief Executive Officer as the interim Chief Financial Officer and Key Managerial Personnel of the Company in accordance with Section 203 of the Companies Act 2013. The appointment shall be effective from December 01 2025 and shall remain in force until a new CFO is appointed by the Board of Directors and assumes office as the CFO.",
      "source": "BSE"
    },
    {
      "caption": "Appointment Of Internal Auditor Of The Company Under Section 138 Of The Companies Act 2013.",
      "datetime": "01-Dec-2025",
      "details": "Appointment of Mr. Vijay S Shanbhag the Chief Internal Auditor of the Company as the Internal Auditor under Section 138 of the Companies Act 2013 effective from December 01 2025 for a term of 6 months.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "22-Nov-2025",
      "details": "Further to our intimation dated November 11 2025 regarding the virtual Investor and Analyst Meet scheduled on December 04 2025 to share updates on the Companys business strategy and long-term growth plans please find enclosed the meeting invite along with the registration link for participation.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Health.Global technically bullish or bearish?

2025-12-04 08:43:09

Overview of Current Technical Trend

As of 3 December 2025, Health.Global's technical trend has shifted from a clear bullish stance to a mildly bullish one. This subtle change indicates that while the stock retains some upward momentum, the strength of the trend has softened. Investors should note that a mildly bullish trend often signals a period of consolidation or a potential pause before the next significant move.

Key Technical Indicators: Mixed Signals

Examining the Moving Average Convergence Divergence (MACD), a widely used momentum indicator, reveals a split between weekly and monthly perspectives. The weekly MACD is mildly bearish, suggesting short-term momentum is weakening. Conversely, the monthly MACD remains bullish, indicating that t...

Healthcare Global Enterprises Sees Mixed Technical Signals Amid Price Momentum Shift

2025-12-04 08:11:33

Healthcare Global Enterprises, a key player in the hospital sector, has experienced a nuanced shift in its technical parameters, reflecting a complex interplay of price momentum and indicator signals. Recent market data reveals a transition from a bullish to a mildly bullish trend, with mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting a cautious outlook for investors.

Healthcare Global Enterprises Shows Mixed Technical Signals Amid Strong Long-Term Returns

2025-12-03 08:07:51

Healthcare Global Enterprises, a key player in the hospital sector, is exhibiting a nuanced shift in its technical momentum as recent evaluation adjustments reflect a transition from mildly bullish to bullish trends. While short-term indicators present a mixed picture, the company’s long-term returns continue to outpace broader market benchmarks, underscoring its resilience in a competitive industry.

Healthcare Global Enterprises Shows Mixed Technical Signals Amid Price Momentum Shift

2025-12-02 08:10:37

Healthcare Global Enterprises has experienced a nuanced shift in its technical landscape, reflecting a complex interplay of momentum indicators and moving averages. Recent price action and technical parameters suggest a transition from a bullish to a mildly bullish trend, with key indicators offering a mixed outlook for investors analysing the hospital sector stock.

Healthcare Global Enterprises Sees Shift in Market Assessment Amid Mixed Financial Signals

2025-11-25 08:51:33

Healthcare Global Enterprises has experienced a notable revision in its market evaluation, reflecting changes across quality, valuation, financial trends, and technical indicators. This shift comes amid a backdrop of strong long-term returns contrasted by recent flat financial performance and elevated debt levels, prompting a nuanced reassessment of the hospital sector stock.

Is Health.Global overvalued or undervalued?

2025-11-25 08:19:35

Understanding Health.Global’s Valuation Metrics

At first glance, Health.Global’s price-to-earnings (PE) ratio stands at an exceptionally elevated level, exceeding 280. This figure is significantly higher than typical industry standards and peer averages, which might initially suggest overvaluation. However, the company’s price-to-book value of around 11 and an enterprise value to EBITDA multiple near 27.5 indicate that investors are pricing in substantial growth potential and operational efficiency.

Moreover, the enterprise value to capital employed ratio of approximately 4.7 and EV to sales near 4.9 further illustrate that the market is valuing the company’s capital base and revenue generation at a premium. These multiples, while high, are not unprecedented in the hos...

Healthcare Global Enterprises: Valuation Shifts Highlight Price Attractiveness in Hospital Sector

2025-11-25 08:00:46

Healthcare Global Enterprises has experienced a notable revision in its valuation parameters, reflecting a shift in market assessment that positions the stock as more price attractive relative to its historical and peer benchmarks. This development invites a closer examination of key financial metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios within the context of the hospital sector.

Healthcare Global Enterprises: An In-Depth Analysis of Business Fundamentals and Market Performance

2025-11-25 08:00:06

Healthcare Global Enterprises has recently undergone a revision in its evaluation metrics, reflecting changes in its business fundamentals and market standing. This article analyses key financial parameters such as return on equity, return on capital employed, debt levels, and growth trends to provide a comprehensive view of the company's current position within the hospital sector.

How has been the historical performance of Health.Global?

2025-11-24 23:20:59

Revenue and Operating Performance

Health.Global’s net sales have shown consistent growth, rising from ₹978.67 crores in March 2019 to ₹2,222.85 crores in March 2025. This represents a compound annual growth rate (CAGR) of approximately 15.5%, reflecting the company’s expanding market presence and operational scale. Total operating income mirrors this trend, as other operating income remained nil throughout the period.

The company’s operating profit before depreciation and interest (PBDIT) excluding other income increased from ₹125.19 crores in 2019 to ₹387.28 crores in 2025, with operating profit margins stabilising around 17.4% in recent years. This improvement underscores enhanced operational efficiency and cost management, despite rising expenditure on purchases of ...

View All News

Announcement

Announcement under Regulation 30 (LODR)-Change in Management

01-Dec-2025 | Source : BSE

Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that based on the recommendation of the Audit Committee and the Nomination and Remuneration Committee the Board of Directors of the Company at its meeting held on December 01 2025 has approved the appointment of Dr. Manish Mattoo Executive Director and Chief Executive Officer as the interim Chief Financial Officer and Key Managerial Personnel of the Company in accordance with Section 203 of the Companies Act 2013. The appointment shall be effective from December 01 2025 and shall remain in force until a new CFO is appointed by the Board of Directors and assumes office as the CFO.

Appointment Of Internal Auditor Of The Company Under Section 138 Of The Companies Act 2013.

01-Dec-2025 | Source : BSE

Appointment of Mr. Vijay S Shanbhag the Chief Internal Auditor of the Company as the Internal Auditor under Section 138 of the Companies Act 2013 effective from December 01 2025 for a term of 6 months.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

22-Nov-2025 | Source : BSE

Further to our intimation dated November 11 2025 regarding the virtual Investor and Analyst Meet scheduled on December 04 2025 to share updates on the Companys business strategy and long-term growth plans please find enclosed the meeting invite along with the registration link for participation.